FILTER

FILTERED INTERVIEW RESULTS

David Cory

CEO, EIGER BIOPHARMACEUTICALS
Founded in 2008, Eiger BioPharmaceuticals is a late-stage biopharmaceutical company focused on developing and commercializing targeted therapies for rare diseases.

Barbara Weber

CEO, TANGO THERAPEUTICS
Tango Therapeutics is targeting unaddressed disease mechanisms in cancer to develop transformational new drugs for patients.

Michael Bigham & Evan Loh

PARATEK PHARMACEUTICALS
Paratek focuses on drugs that target infectious disease and other difficult-to-treat conditions.

Richard Peters

PRESIDENT AND CEO, MERRIMACK PHARMACEUTICALS
Merrimack Pharmaceuticals is focused on cancer treatment through a deeper understanding of cancer pathways and biological markers.

Ankit Mahadevia & Cristina Larkin

CEO & CHIEF COMMERCIAL OFFICER, SPERO THERAPEUTICS
Spero Therapeutics is developing new antimicrobial drugs to substitute those that have become ineffectual as they meeting resistance.

Travis McCready

PRESIDENT & CEO, MASSACHUSETTS LIFE SCIENCES CENTER
The Massachusetts Life Sciences Center has spent a billion dollars to ensure the best possible environment for the life sciences industry.

Robert K. Coughlin

PRESIDENT & CEO, MASSACHUSETTS BIOTECHNOLOGY COUNCIL
Founded in 1985, MassBio’s mission is to advance Massachusetts’ leadership in life sciences to grow the industry.

Naresh Raisinghani

CEO & EXECUTIVE DIRECTOR, BMGI INDIA
BMGI India offers expertise is improving efficiencies in strategy, innovation, problem solving and business transformation.

Akshay Singh

MANAGING DIRECTOR, SGD PHARMA INDIA
Cogent Glass, recently acquired by SGD Pharma, is a manufacturer of Type I moulded and tubular glass vials for the pharmaceutical industry.

Harish Shah

MANAGING DIRECTOR, SIGNET
Signet is India’s largest excipient company with extensive activities extending to Bangladesh and the Middle East.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Africa Energy 2024 - Pre-release

The pre-release edition of Africa Energy 2024 comprises analysis based on over 80 interviews with ministers and leading executives from IOCs, NOCs, independents, associations, investors and service providers, to provide an in-depth and holistic view of sub-Saharan Africa’s ever-evolving energy sector.

PARTNER EVENTS